Theravance Biopharma (TBPH) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Rick Winningham - CEORhonda Farnum - Chief Business Officer and Senior VP of Commercial & Medical AffairsAziz Sawaf - SVP - Operations & Strategy and CFOAine Miller - SVP - Development & Head of Ireland Office Conference Call Participants Marc Frahm - AnalystNone - Analyst Operator Hello, ladies and gentlemen. Good afternoon. I would like to welcome everyone to the Theravance Biopharma First Quarter twenty twenty ...

SÃO PAULO, May 6, 2025 /PRNewswire/ -- EMBRAER S.A. (NYSE: ERJ; B3: EMBR3) RELEASES ITS FIRST QUARTER 2025 EARNINGS RESULTS.HIGHLIGHTS 2025 Guidance reiterated: Commercial Aviation deliveries between 77 and 85 aircraft, and Executive Aviation deliveries between 145 and 155 aircraft. Total company revenues in the US$7.0 to US$7.5 billion range, adjusted EBIT margin between +7.5% and +8.3%, and adjusted free cash flow of US$200 million or higher for the year. The company highlights Q1 results were not impacte ...

Group 1 - The peak earnings season is starting this week, with 7,600 companies, representing 70% of the equity universe, expected to report in the next three weeks [5] - Attention is particularly focused on major technology companies, referred to as the Magnificent 7, for indications of growth [5]

Monday, April 28, 2025 Considering how the sky had been falling for much of this month on Wall Street, we're not doing so badly overall. Today saw a mid-day dip across major indexes, but rebounded into the green by the end of the session — all but the tech-heavy Nasdaq. The Dow gained +114 points on the day, +0.28% — after hitting -244 points at its session lows — while the S&P 500 finished +0.06%, essentially flat. The Nasdaq was mostly flat today, as well: -0.10%, while the small- cap Russell 2000 rose +0 ...